Background: We examined the effects of interferon-gamma (IFN-gamma) on protein production of extracellular matrix (ECM) components in cultured human subconjunctival fibroblasts or those stimulated by exogenous transforming growth factor beta1 (TGFbeta1). IFN-gamma reportedly up-regulates Smad7, an inhibitory mediator of TGFbeta-Smad signaling, and blocks TGFbeta effects.
Methods: Proliferation and migration as well as the ultrastructure of these cells were examined in the presence and absence of IFN-gamma. Cell migration was examined using an in vitro wound healing model in monolayer fibroblast cultures.
Results: The results showed that IFN-gamma reduced ECM production in normal subconjunctival fibroblasts, as well as in those treated with TGFbeta1, below the control levels. IFN-gamma had no effect on cell proliferation and fibroblast ultrastructure. On the other hand, IFN-gamma delayed defect closure in monolayer cell sheets in a dose-dependent manner. Immunohistochemistry also revealed that the addition of IFN-gamma attenuated the translocation of Smads2/4 into the nuclei of TGFbeta1-treated subconjunctival fibroblasts.
Conclusion: These findings suggest that IFN-gamma may be clinically effective in attenuating excessive ECM accumulation in conjunctiva after ocular surgery and in the presence of inflammatory ocular surface disorder. IFN-gamma modulates the Smads2/4 pathway of TGFbeta1 signal transduction toward the up-regulation of ECM components.